×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
EU legislation impact on global requirements & QPPV oversight
Session Chair(s)
Brian Edwards, DrMed
Vice President
International Society of Pharmacovigilance, United Kingdom
Personal Perspectives on Practicality of Being a QPPV in a Global System
Speaker(s)
Personal Perspectives on Practicality of Being a QPPV in a Global System
Sue Rees, MS
Sue Rees Consultancy Ltd, United Kingdom
Director
Benefit/Risk for the PBRER of Mature Products - Is this a waste of our time or an opportunity?
Anna Van Troostenburg
Gilead Sciences International Ltd., Germany
Head PV Quality Governance, EU QPPV & VP
Risk Management: Company standards versus local requirements
Michael Richardson, MD, FFPM, FRCP
Bristol-Myers Squibb, United Kingdom
Senior Vice President, WorldWide Patient Safety
Have an account?